Immune activation in murine AIDS (MAIDS) has been suggested to involve a superantigen (SAG). The possibility that SAGs encoded by mammary tumor virus (MTV) might be the source of stimulation was studied by using Mtv mice. Mtv ؊ mice developed typical MAIDS, excluding a requirement for Mtv-encoded SAGs in the pathogenesis of this disorder.
Immune activation in murine AIDS (MAIDS) has been suggested to involve a superantigen (SAG). The possibility that SAGs encoded by mammary tumor virus (MTV) might be the source of stimulation was studied by using Mtv mice. Mtv ؊ mice developed typical MAIDS, excluding a requirement for Mtv-encoded SAGs in the pathogenesis of this disorder.
Infection of C57BL/6 (B6) mice with a murine leukemia virus (MuLV) mixture that includes an etiologic replicationdefective virus (BM5def) induces the rapid onset of lymphoproliferation and immunodeficiency, a syndrome termed murine AIDS (MAIDS) (2-4, 17, 24, 25) . Several observations have suggested the involvement of a superantigen (SAG) in the pathogenesis of this disorder. First, the early course of the disease is associated with a modest preferential expansion of V␤5 ϩ CD4 ϩ T cells (26, 30) and nearly complete deletion of CD4 ϩ T cells expressing V␤5.2 (27) followed by progression to polyclonal T-cell involvement (25, 26) . In addition, B-cell lymphomas recovered from mice with MAIDS were found to preferentially stimulate in vitro proliferation of T cells expressing V␤5, V␤11, and V␤12 (14) (15) (16) 19) . Finally, it has been shown that CD4
ϩ T cells (32) and major histocompatibility complex class II molecules (12) are required for development of MAIDS, as they are for most aspects of SAG-induced changes in the immune system. Although initial studies suggested that the Gag protein encoded by BM5def might be a SAG (14) (15) (16) 19) , there has been no direct evidence to support this view. Studies indicating that BM5def does not encode a SAG have been published recently (7) , and the polyclonal nature of T-cell activation seen in MAIDS has led others to suggest that a SAG is not involved in the pathogenesis of this disease (9, 26, 27) .
The known SAGs of the mouse are encoded by genes in the 3Ј long terminal repeats of vertically transmitted or endogenous mammary tumor viruses (MTVs) and are designated viral SAGs (vSAGs) (1, 8, 10, 22) . It was postulated that vSAGs, rather than a SAG encoded by the MuLV that induces MAIDS, might be the source of antigenic drive in this syndrome (28) . Consistent with this postulate, B6 mice express vSags from Mtv8, Mtv9, and Mtv17 genes, which mediate the activation and deletion of T cells expressing the V␤ specificities shown to be altered in vivo or in vitro in association with MAIDS. To test whether expression of vSAGs is required for induction of MAIDS, we examined the course of MAIDSinducing MuLV infection in Mtv Ϫ mice. Mtv Ϫ mice were generated by inbreeding the F 2 progeny of CBA/CaJ and C58/J mice as recently described (29) and are designated here as C.Mtv Ϫ mice. C.Mtv Ϫ mice were crossed with BALB.B, a strain highly susceptible to MAIDS (21) , and Mtv Ϫ progeny were selected. Stocks of LP-BM5 MuLV prepared from the G6 clone of chronically infected SC-1 cells as described previously (13, 32) contain nonpathogenic, replication-competent, B-tropic ecotropic, and mink cell focus-inducing MuLV and BM5def. Ntropic amphotropic (4070A) MuLV pseudotypes of the 1/27/A1 molecular clone of BM5def (4) were prepared from supernatants of Mus dunni cells chronically infected by cotransfection with 1/27/A1 and 4070A DNAs by calcium precipitation (23) . Mice were infected with 0.1 ml of virus stocks given intraperitoneally (i.p.) at 4 to 8 weeks of age or with 0.02 ml given i.p. within 48 h of birth.
Virus recovery from mice was determined by infectiouscenter assays of mitomycin C-treated spleen cells (5, 6) . Spleen cells were also stained with a panel of antibodies used in fluorescence-activated cell sorter (FACS) analyses for staging the progression of MAIDS. The histopathologic and FACS criteria used to follow the progression of MAIDS have been described in detail (20, 21) . Briefly, N indicates normal, R indicates a change associated with infection but of insufficient severity to be diagnostic of MAIDS, and stages 1 through 3 are MAIDS-diagnostic changes of increasing severity.
The two strains used in the generation of Mtv Ϫ mice were both quite resistant to induction of MAIDS, exhibiting disease only after prolonged periods of latency following infections as adults or newborns; C.Mtv Ϫ mice were equally resistant (data not shown).
To generate C.Mtv Ϫ mice that were susceptible to MAIDS, C.Mtv Ϫ mice were crossed with the MAIDS-sensitive strain BALB.B (22) Among mice homozygous for Fv-1 b , four of four studied at 13 weeks and two of seven studied at 20 weeks after infection had advanced lymphoproliferation and clear-cut diagnostic cri-teria for MAIDS as determined by histopathology; six of the diagnoses were confirmed by FACS analyses (Table 1 ). Another mouse from this set, with a spleen weight of only 130 mg, was diagnosed with early MAIDS by histopathology. A moderate proportion of spleen cells from two of the mice diagnosed with MAIDS expressed ecotropic virus, and all expressed BM5def by reverse transcription-PCR (11, 12) .
Three of five Fv-1 n mice autopsied at 27 to 28 weeks had prominent lymphoproliferation and were diagnosed with unequivocal MAIDS by histopathologic criteria in all cases, with confirmatory evidence by FACS in one case (Fig. 1) . Figure 1 shows that the characteristic alterations seen in MAIDS were observed in the 28-week-infected mouse: reduced frequencies of Thy-1 ϩ cells, increased frequencies of cells expressing low levels of immunoglobulin kappa light chain and CD45R (B220), an increased frequency of CD11b(Mac-1) ϩ cells, enhanced expression of immunoglobulin G FcRII/III, and substantial numbers of cells staining at low intensity with antiimmunoglobulin G monoclonal antibodies.
Finally, all the Fv-1 n and Fv-1 b mice in these assays were shown to be Mtv Ϫ by both reverse transcription-PCR and DNA-PCR analyses (data not shown).
Our data clearly demonstrate that MTV is not required for induction of MAIDS. Lymphoproliferation and unmistakable (29) . Although the existence of nonviral cellular SAGs that might influence positive or negative selection of T cells has been postulated from studies of other systems (17, 18) , the evidence in support of this notion is not compelling. If all SAGs are encoded by Mtv genes, the induction of MAIDS in Mtv Ϫ mice suggests the involvement of a unique type of major histocompatibility complex class II-binding molecule with broad T-cell reactivity, since essentially all T cells in the periphery show signs of activation in MAIDS (25) (26) (27) . This type of T-cell reaction is more characteristic of mitogens than of antigens, although mitogens are not dependent on major histocompatibility complex class II molecules for presentation. The nature of the molecule responsible for T-cell activation in MAIDS thus remains an enigma.
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